Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.
Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P, Agrup M, Dahl L, Gubanski M, Gojon H, Brahme CJ, Rydén I, Jakola AS, Vik-Mo EO, Lie HC, Asphaug L, Hervani M, Kristensen I, Rueegg CS, Olsen IC, Ledal RJ, Degsell E, Werlenius K, Blomstrand M, Brandal P. Heggebø LC, et al. Among authors: werlenius k. BMJ Open. 2023 Mar 20;13(3):e070071. doi: 10.1136/bmjopen-2022-070071. BMJ Open. 2023. PMID: 36940951 Free PMC article.
[Inconclusive data].
Kinhult S, Werlenius K, Hallbeck AL, Nyström PW, Männikkö V, Johansson M. Kinhult S, et al. Among authors: werlenius k. Lakartidningen. 2014 Jul 2-15;111(27-28):1192. Lakartidningen. 2014. PMID: 25162111 Swedish. No abstract available.
[Questionable effect of antiviral therapy in malignant brain tumors].
Kinhult S, Werlenius K, Hallbeck AL, Nyström PW, Männikkö V, Johansson M. Kinhult S, et al. Among authors: werlenius k. Lakartidningen. 2014 Apr 29-May 13;111(18-19):809. Lakartidningen. 2014. PMID: 24855749 Free article. Swedish. No abstract available.
Proton therapy for low-grade gliomas in adults: A systematic review.
Thurin E, Nyström PW, Smits A, Werlenius K, Bäck A, Liljegren A, Daxberg EL, Jakola AS. Thurin E, et al. Among authors: werlenius k. Clin Neurol Neurosurg. 2018 Nov;174:233-238. doi: 10.1016/j.clineuro.2018.08.003. Epub 2018 Aug 8. Clin Neurol Neurosurg. 2018. PMID: 30292166
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.
Jakola AS, Werlenius K, Mudaisi M, Hylin S, Kinhult S, Bartek J Jr, Salvesen Ø, Carlsen SM, Strandéus M, Lindskog M, Löfgren D, Rydenhag B, Carstam L, Gulati S, Solheim O, Bartek J, Solheim T. Jakola AS, et al. Among authors: werlenius k. F1000Res. 2018 Nov 15;7:1797. doi: 10.12688/f1000research.16786.1. eCollection 2018. F1000Res. 2018. PMID: 30647912 Free PMC article.
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma.
Werlenius K, Stragliotto G, Strandeus M, Blomstrand M, Carén H, Jakola AS, Rydenhag B, Dyregaard D, Dzhandzhugazyan KN, Kirkin AF, Raida MK, Smits A, Kinhult S. Werlenius K, et al. Neurooncol Adv. 2021 Oct 22;3(1):vdab156. doi: 10.1093/noajnl/vdab156. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34765977 Free PMC article.
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial.
Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J Jr, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS. Werlenius K, et al. JAMA Netw Open. 2023 Mar 1;6(3):e234149. doi: 10.1001/jamanetworkopen.2023.4149. JAMA Netw Open. 2023. PMID: 37000452 Free PMC article. Clinical Trial.
12 results